Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BODY MASS INDEX, MODIFIER OF
|
1 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.700 | 0 | |||||||||
DIABETES MELLITUS, NONINSULIN-DEPENDENT, MODIFIER OF
|
1 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.700 | 0 | |||||||||
INTIMAL MEDIAL THICKNESS OF INTERNAL CAROTID ARTERY, MODIFIER OF
|
1 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.700 | 0 | |||||||||
OBESITY, MODIFIER OF
|
1 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.700 | 0 | |||||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.893 | 103 | 1997 | 2018 | ||||||
Obesity
|
1111 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.837 | 43 | 1997 | 2018 | ||||||
Diabetes Mellitus
|
824 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.842 | 38 | 1999 | 2019 | ||||||
Hyperinsulinism
|
64 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.090 | 1.000 | 9 | 1999 | 2013 | ||||||
Diabetes
|
710 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.813 | 32 | 2000 | 2019 | ||||||
Impaired glucose tolerance
|
81 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.040 | 1.000 | 4 | 2000 | 2012 | ||||||
Metabolic Syndrome X
|
591 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.955 | 22 | 2001 | 2014 | ||||||
Hypertensive disease
|
1085 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.060 | 0.667 | 6 | 2001 | 2019 | ||||||
Malignant Neoplasms
|
1641 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.050 | 1.000 | 5 | 2001 | 2010 | ||||||
Primary malignant neoplasm
|
1374 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.050 | 1.000 | 5 | 2001 | 2010 | ||||||
Insulin resistance syndrome
|
15 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.040 | 1.000 | 4 | 2001 | 2002 | ||||||
Dyslipidemias
|
184 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.020 | 1.000 | 2 | 2001 | 2014 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
obsolete Combined hyperlipidemia
|
4 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
Renal Cell Carcinoma
|
288 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.778 | 18 | 2002 | 2013 | ||||||
Breast Carcinoma
|
2793 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.050 | 0.800 | 5 | 2002 | 2017 | ||||||
Malignant neoplasm of breast
|
3417 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.050 | 0.800 | 5 | 2002 | 2017 | ||||||
Lipid Metabolism Disorders
|
10 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||
Colorectal Carcinoma
|
1962 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.100 | 0.800 | 10 | 2003 | 2010 | ||||||
Cardiovascular Diseases
|
711 | 0.510 | 0.840 | 3 | 12379739 | missense variant | C/G | snv | 0.060 | 0.833 | 6 | 2003 | 2016 |